SCM
BTMDW

Shaolin Capital Management’s Biote Corp. Warrant BTMDW Stock Holding History

Shaolin Capital Management’s Portfolio BTMDW Stock Details BTMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-47,389
Closed -$34K – 1020
2021
Q4 		$34K Buy
+47,389
New +$38.2K ﹤0.01% 721

Other funds holding BTMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Shaolin Capital Management's BTMDW Position: Q1 2022 in Review

Shaolin Capital Management sold out of Biote Corp. Warrant (BTMDW) in Q1 2022, closing a stake of 47,389 shares — an estimated $34K sold.

Shaolin Capital Management first reported a position in BTMDW in Q4 2021 and held it in 1 quarter. The position peaked at $34K in Q4 2021. 51 funds tracked by Wall St. Rank hold BTMDW as of Q1 2022.

  • Shaolin Capital Management reported no remaining Biote Corp. Warrant position as of Q1 2022 after selling out during the quarter.
  • Shaolin Capital Management sold 47,389 Biote Corp. Warrant shares in Q1 2022, an estimated $34K.
  • Shaolin Capital Management first reported a position in Biote Corp. Warrant in Q4 2021 and held it in 1 quarter.
  • Shaolin Capital Management's Biote Corp. Warrant position peaked at $34K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q1 2022.

Based on Shaolin Capital Management's 13F filing for Q1 2022, filed 13 May 2022.